FrederickEdwardMillardMD

Oncology • La Jolla, CA

Genitourinary Oncology

Clinical Professor of Medicine at UC San Diego Moores Cancer Center

Join to view full profile

Dr. Millard is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Millard's full profile

Already have an account?

Office
3855 Health Sciences Drive
Moores UCSD Cancer Center , MC 0987
La Jolla, CA 92093
Phone+1 858-822-6185

Fax+1 858-249-0905
Is this information wrong?

Education & Training

Naval Medical Center (San Diego)Fellowship, Hematology and Medical Oncology, 1984 - 1987
Naval Medical Center (San Diego)Residency, Internal Medicine, 1982 - 1984
Naval Medical Center (San Diego)Internship, Internal Medicine, 1980 - 1981
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1980

Certifications & Licensure

CA State Medical License 1984 - 2026
PA State Medical License 1990 - 2000
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013

Clinical Trials

Evaluation of Transgenic Lymphocyte Immunization Vaccine in Subjects With Prostate Adenocarcinoma Start of enrollment: 2003 Apr 01
Completed
Phase 1
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer Start of enrollment: 2009 Jul 15
Completed
Phase 3
A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies Start of enrollment: 2009 Dec 11
Completed
Phase 1
A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer Start of enrollment: 2011 Jun 01
Unknown status
Phase 1, Phase 2
Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery Start of enrollment: 2012 Aug 08
Active, not recruiting
Phase 3
S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer Start of enrollment: 2013 Mar 08
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

4 citations
Germline alterations among Hispanic men with prostate cancer.
Elizabeth Pan, Justin Shaya, Lisa Madlensky, J Michael Randall, Juan Javier-Desloges, Frederick E Millard, Brent Rose, J Kellogg Parsons, Sarah M Nielsen, Kathryn E Ha...> ;Prostate Cancer and Prostatic Diseases. 2022 Sep 1
5 citations
The Prognostic Significance of Homologous Recombination Repair Pathway Alterations in Metastatic Hormone Sensitive Prostate Cancer.
Aaron M Lee, Ava Saidian, Justin Shaya, Taylor Nonato, Angelo Cabal, J Michael Randall, Frederick Millard, Tyler Stewart, Brent Rose, Pablo Tamayo, Rana R McKay> ;Clinical Genitourinary Cancer. 2022 Dec 1
Correction: Germline alterations among Hispanic men with prostate cancer.
Elizabeth Pan, Justin Shaya, Lisa Madlensky, J Michael Randall, Juan Javier-Desloges, Frederick E Millard, Brent Rose, J Kellogg Parsons, Sarah M Nielsen, Kathryn E Ha...> ;Prostate Cancer and Prostatic Diseases. 2022 Sep 1
33 citations
IL-7 expands lymphocyte populations and enhances immune responses to sipuleucel-T in patients with metastatic castration-resistant prostate cancer (mCRPC).
Russell K. Pachynski, Chihiro Morishima, Russell Z. Szmulewitz, Lauren C. Harshman, Leonard Joseph Appleman, Paul Monk, Rhonda L. Bitting, Omer Kucuk, Frederick Millar...> ;Journal for Immunotherapy of Cancer. 2021 Aug 1
3 citations
Analysis of the Prognostic Significance of Circulating Tumor DNA in Metastatic Castrate Resistant Prostate Cancer
Justin Shaya, Taylor Nonato, Angelo Cabal, James Michael Randall, Frederick Millard, Tyler F. Stewart, Rana R. McKay> ;Clinical Genitourinary Cancer. 2020 Feb 19
22 citations
Neoadjuvant Sunitinib Decreases Inferior Vena Caval Thrombus Size and Is Associated With Improved Oncologic Outcomes: A Multicenter Comparative Analysis.
Charles Field, Brittney Cotta, Juan Jimenez, Brian R. Lane, Kendrick Yim, Hak J. Lee, Stephen Ryan, Zachary Hamilton, Sunil Patel, Song Wang, Christopher J. Kane, Sumi...> ;Clinical Genitourinary Cancer. 2019 Jan 30
186 citations
Adolescent and Young Adult Oncology, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.
Peter F. Coccia, Alberto S. Pappo, Lynda K. Beaupin, Virginia F. Borges, Scott C. Borinstein, Rashmi Chugh, Shira Dinner, Jeanelle Folbrecht, A. Lindsay Frazier, Rober...> ;Journal of the National Comprehensive Cancer Network. 2018 Jan 1
45 citations
Neoadjuvant therapy for localized and locally advanced renal cell carcinoma.
Ahmet Bindayi, Zachary Hamilton, Michelle L. McDonald, Kendrick Yim, Frederick Millard, Rana R. McKay, Steven C. Campbell, Brian I. Rini, Ithaar Derweesh> ;Urologic Oncology. 2018 Jan 1
8 citations
Renal Functional Outcome of Partial Nephrectomy for Complex R.E.N.A.L. Score Tumors With or Without Neoadjuvant Sunitinib: A Multicenter Analysis.
Michelle L. McDonald, Brian R. Lane, Juan Jimenez, Hak J. Lee, Kendrick Yim, Ahmet Bindayi, Zachary Hamilton, Charles Field, Aaron Bloch, Sumi Dey, Sabrina L. Noyes, R...> ;Clinical Genitourinary Cancer. 2017 Sep 25
7 citations
Change in platelet count as a prognostic indicator for response to primary tyrosine kinase inhibitor therapy in metastatic renal cell carcinoma
Zachary Hamilton, Hak J. Lee, Juan Jimenez, Brian R. Lane, Song Wang, Alp Tuna Beksac, Kyle Gillis, Amy Alagh, Conrad M. Tobert, James Michael Randall, Christopher J. ...> ;BJU International. 2016 Dec 1
9 citations
Does timing of targeted therapy for metastatic renal cell carcinoma impact treatment toxicity and surgical complications? A comparison of primary and adjuvant approaches.
Nishant Patel, Jason Woo, Michael A. Liss, Kerrin Palazzi, J. Michael Randall, Reza Mehrazin, Ramzi Jabaj, Hossein S. Mirheydar, Kyle Gillis, Hak J. Lee, Anthony L. Pa...> ;The Canadian Journal of Urology. 2016 Apr 1
78 citations
Phase 2 trial of dovitinib in patients with progressive FGFR3-mutated or FGFR3 wild-type advanced urothelial carcinoma
Matthew I. Milowsky, Christian Dittrich, Ignacio Duran, Satinder Jagdev, Frederick Millard, Christopher Sweeney, Dean F. Bajorin, Linda Cerbone, David I. Quinn, Walter...> ;European Journal of Cancer. 2014 Dec 1
3 citations
What is the Incidence of Kidney Stones after Chemotherapy in Patients with Lymphoproliferative or Myeloproliferative Disorders
Hossein S. Mirheydar, Pooya Banapour, Rustin Massoudi, Kerrin Palazzi, Ramzi Jabaji, Erin Reid, Frederick Millard, Christopher J. Kane, Roger L. Sur> ;International Braz j Urol. 2014 Dec 1
65 citations
Molecular aberrations, targeted therapy, and renal cell carcinoma: current state-of-the-art
J. Michael Randall, Frederick Millard, Razelle Kurzrock> ;Cancer Metastasis Reviews. 2014 Nov 4
1 citations
An open-label study to investigate the cardiac safety profile of cabazitaxel in patients with advanced solid tumors.
Pierre Maison-Blanche, Shaker R. Dakhil, Ari David Baron, Sylvie Rottey, Fred Millard, Gedske Daugaard, Jean-Pascal Machiels, William A. Conkright, Sunil Sharma, Patri...> ;Cancer Chemotherapy and Pharmacology. 2014 Apr 10
20 citations
The effect of prior androgen synthesis inhibition on outcomes of subsequent therapy with docetaxel in patients with metastatic castrate-resistant prostate cancer: resu...
Rahul Aggarwal, Susan Halabi, William Kevin Kelly, Daniel J. George, John Francis Mahoney, Frederick Millard, Walter M. Stadler, Michael J. Morris, Philip W. Kantoff, ...> ;Cancer. 2013 Oct 15
31 citations
Does timing of cytoreductive nephrectomy impact patient survival with metastatic renal cell carcinoma in the tyrosine kinase inhibitor era? A multi-institutional study.
Sean P. Stroup, Omer A. Raheem, Kerrin L. Palazzi, Michael A. Liss, Reza Mehrazin, Ryan Kopp, Nishant Patel, Seth A. Cohen, Samuel K. Park, Anthony L. Patterson, Chris...> ;Urology. 2013 Apr 1
Reply.
Derweesh, I. H.,Stroup, S. P.,Millard, F.> ;Urology. 2013 Feb 19
11 citations
Are Repeat Prostate Biopsies Safe? A Cohort Analysis From the SEARCH Database
Ryan Kopp, Sean P. Stroup, Florian R. Schroeck, Stephen J. Freedland, Frederick Millard, Martha K. Terris, William J. Aronson, Joseph C. Presti, Christopher L. Amling,...> ;The Journal of Urology. 2012 Jun 1
A QTc study of cabazitaxel in patients with advanced solid tumors.
Wade JL, Dakhil SR, Baron AD, Rottey S, Millard FE, Daugaard G, Machiels JH, Conkright WA, Sharma S, Soetekouw PMMB, Yachnin J, Sengeløv L, van Veldhuizen P, Agarwala ...> ;J. Clin. Oncol.. 2012-02-10
18 citations
Update on Chemotherapy in the Treatment of Urothelial Carcinoma
Carrie Costantini, Frederick Millard> ;Thescientificworldjournal. 2011 Oct 26
3 citations
Target Localization and Toxicity in Dose-Escalated Prostate Radiotherapy with Image-Guided Approach using Daily Planar Kilovoltage Imaging:
Sameer K. Nath, Ajay Sandhu, R.A. Sethi, Lindsay G. Jensen, M. D. Rosario, Christopher J. Kane, J.K. Parsons, Frederick Millard, Steve B. Jiang, R Rice, Todd Pawlicki,...> ;Technology in Cancer Research & Treatment. 2011 Feb 1
73 citations
Feasibility and efficacy of neoadjuvant sunitinib before nephron‐sparing surgery
Jonathan L. Silberstein, Frederick Millard, Reza Mehrazin, Ryan Kopp, Wassim M. Bazzi, Christopher J. DiBlasio, Anthony L. Patterson, Tracy M. Downs, Furhan Yunus, Chr...> ;BJU International. 2010 Nov 1
51 citations
Toxicity Analysis of Postoperative Image-Guided Intensity-Modulated Radiotherapy for Prostate Cancer
Sameer K. Nath, Ajay P. Sandhu, Brent S. Rose, Daniel R. Simpson, P.D. Nobiensky, J Wang, Fred Millard, Christopher J. Kane, J. Kellogg Parsons, Arno J. Mundt> ;International Journal of Radiation Oncology, Biology, Physics. 2010 Oct 1
Phase I and pharmacokinetic study of sorafenib in patients with hepatic or renal dysfunction: CALGB 60301.
Miller AA Murry DJ Owzar K Hollis DR Kennedy EB Abou-Alfa G Desai A Hwang J Villalona-Calero MA Dees EC Lewis LD Fakih MG Edelman MJ Millard F Frank RC Hohl RJ Ratain MJ > ;J Clin Oncol . 2009 Apr 10
Join now to see all